Kezar Life Sciences, Inc.KZRNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank56
5Y CAGR-31.8%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-31.8%/yr
Long-term compound
Percentile
P56
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$227000.00-
2024$0.00-
2023$0.00-
2022$0.00-100.0%
2021$1.51M-2.2%
2020$1.54M+18.7%
2019$1.30M+88.6%
2018$690000.00+294.3%
2017$175000.00+13.6%
2016$154000.00-